Correction: Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study)

被引：0
|
作者：
Piero Barbanti
Gabriella Egeo
Cinzia Aurilia
Florindo d’Onofrio
Maria Albanese
Ilaria Cetta
Paola Di Fiore
Maurizio Zucco
Massimo Filippi
Francesco Bono
Claudia Altamura
Stefania Proietti
Stefano Bonassi
Fabrizio Vernieri
机构：
[1] Headache and Pain Unit,Neurology Unit
[2] IRCCS San Rafaele Pisana,Regional Referral Headache CenterNeurology Unit
[3] San Rafaele University,Department of Systems Medicine
[4] San Giuseppe Moscati Hospital,Headache Unit, Department of Neurology
[5] University Hospital Tor Vergata,Headache Center, Neurlogy Unit
[6] University of Rome Tor Vergata,Neurology Unit, IRCCS San Rafaele Scientifc Institute
[7] Scientifc Institute San Rafaele Hospital,Headache and Neurosonology Unit
[8] Vita-Salute University,Department of Human Sciences and Quality of Life Promotion
[9] Headache Center,Headache and Neurosonology Unit
[10] ASST Santi Paolo Carlo,undefined
[11] San Camillo-Forlanini Hospital,undefined
[12] Vita-Salute San Raffaele University,undefined
[13] Center for Headache and Intracranial Pressure Disorders,undefined
[14] Neurology Unit,undefined
[15] A.O.U. Mater Domini,undefined
[16] Policlinico Universitario Campus Bio-Medico,undefined
[17] Clinical and Molecular Epidemiology,undefined
[18] IRCCS San Rafaele,undefined
[19] San Rafaele University,undefined
[20] Campus BioMedico University Hospital,undefined
来源：
The Journal of Headache and Pain | 2022年 / 23卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] The real-life early and continuative response to Galcanezumab in chronic migraine: 3-month analysis of the multicenter prospective cohort GARLIT study
    Altamura, C.
    Brunelli, N.
    Costa, C. M.
    Aurilia, C.
    Egeo, G.
    Fofi, L.
    Favoni, V.
    Pierangeli, G.
    Messina, R.
    Filippi, M.
    Colombo, B.
    Lovati, C.
    Aguggia, M.
    Bertuzzo, D.
    D'Onofrio, F.
    Doretti, A.
    Di Fiore, P.
    Frediani, F.
    Finocchi, C.
    Rao, R.
    Di Cola, F. Schiano
    Bono, F.
    Ranieri, A.
    Albanese, M.
    Cevoli, S.
    Barbanti, P.
    Vernieri, F.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 183 - 184
  • [32] The real-life early and continuative response to Galcanezumab in chronic migraine: 3-month analysis of the multicenter prospective cohort GARLIT study
    Altamura, C.
    Brunelli, N.
    Costa, C. M.
    Aurilia, C.
    Egeo, G.
    Fofi, L.
    Favoni, V.
    Pierangeli, G.
    Messina, R.
    Filippi, M.
    Colombo, B.
    Lovati, C.
    Aguggia, M.
    Bertuzzo, D.
    D'Onofrio, F.
    Doretti, A.
    Di Fiore, P.
    Frediani, F.
    Finocchi, C.
    Rao, R.
    Di Cola, F. Schiano
    Bono, F.
    Ranieri, A.
    Albanese, M.
    Cevoli, S.
    Barbanti, P.
    Vernieri, F.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 123 - 123
  • [33] Long term (48-weeks) effectiveness, safety and tolerability of erenumab in the prevention of high-frequency episodic and chronic migraine in real-world: the EARLY 2 study
    Aurilia, C.
    Cevoli, S.
    Egeo, G.
    Fofi, L.
    Messina, R.
    Salerno, A.
    Torelli, P.
    Albanese, M.
    Carnevale, A.
    Bono, F.
    D'Amico, D.
    Filippi, M.
    Altamura, C.
    Vernieri, F.
    Colombo, B.
    Frediani, F.
    Mercuri, B.
    D'Onofrio, F.
    Grazzi, L.
    Aguggia, M.
    Favoni, V.
    Finocchi, C.
    Di Fiore, P.
    Costa, C. M.
    Brunelli, N.
    Fallacara, A.
    Bertuzzo, D.
    Zucco, M.
    Di Clemente, L.
    Trimboli, M.
    Pascarella, A.
    Manzo, L.
    Barbanti, P.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 16 - 16
  • [34] Long term (48-weeks) effectiveness, safety and tolerability of erenumab in the prevention of high-frequency episodic and chronic migraine in real-world: the EARLY 2 study
    Aurilia, C.
    Cevoli, S.
    Egeo, G.
    Fofi, L.
    Messina, R.
    Salerno, A.
    Torelli, P.
    Albanese, M.
    Carnevale, A.
    Bono, F.
    D'Amico, D.
    Filippi, M.
    Altamura, C.
    Vernieri, F.
    Colombo, B.
    Frediani, F.
    Mercuri, B.
    D'Onofrio, F.
    Grazzi, L.
    Aguggia, M.
    Favoni, V.
    Finocchi, C.
    Di Fiore, P.
    Costa, C. M.
    Brunelli, N.
    Fallacara, A.
    Bertuzzo, D.
    Zucco, M.
    Di Clemente, L.
    Trimboli, M.
    Pascarella, A.
    Manzo, L.
    Barbanti, P.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 23 - 23
  • [35] Long term (48-weeks) effectiveness, safety and tolerability of erenumab in the prevention of high-frequency episodic and chronic migraine in real-world: The early 2 study
    Aurilia, Cinzia
    Cevoli, Sabina
    Egeo, Gabriella
    Fofi, Luisa
    Messina, Roberta
    Salerno, Antonio
    Torelli, Paola
    Albanese, Maria
    Carnevale, Antonio
    Bono, Francesco
    D'Amico, Domenico
    Filippi, Massimo
    Altamura, Claudia
    Vernieri, Fabrizio
    Colombo, Bruno
    Frediani, Fabio
    Mercuri, Bruno
    D'Onofrio, Florindo
    Grazzi, Licia
    Aguggia, Marco
    Favoni, Valentina
    Finocchi, Cinzia
    Di Fiore, Paola
    Costa, Carlemina Maria
    Brunelli, Nicoletta
    Fallacara, Adriana
    Bertuzzo, Davide
    Zucco, Maurizio
    Di Clemente, Laura
    Trimboli, Michele
    Pascarella, Angelo
    Manzo, Lucia
    Barbanti, Piero
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [36] Long-term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high-frequency episodic and chronic migraine in a real world: Results of the EARLY 2 study
    Barbanti, Piero
    Aurilia, Cinzia
    Cevoli, Sabina
    Egeo, Gabriella
    Fofi, Luisa
    Messina, Roberta
    Salerno, Antonio
    Torelli, Paola
    Albanese, Maria
    Carnevale, Antonio
    Bono, Francesco
    D'Amico, Domenico
    Filippi, Massimo
    Altamura, Claudia
    Vernieri, Fabrizio
    HEADACHE, 2021, 61 (09): : 1351 - 1363
  • [37] Erenumab and Possible CGRP Effect on Chronotype in Chronic Migraine: A Real-Life Study of 12 Months Treatment
    Pilati, Laura
    Torrente, Angelo
    Di Marco, Salvatore
    Ferlisi, Salvatore
    Notaro, Giulia
    Romano, Marika
    Alonge, Paolo
    Vassallo, Lavinia
    Ferrau, Ludovica
    Autunno, Massimo
    Grugno, Rosario
    Camarda, Cecilia
    Brighina, Filippo
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (10)
  • [38] A Retrospective Real-Life Multicenter Study on Concurrent Oral Preventive Treatments in Patients with Chronic Migraine Treated with OnabotulinumtoxinA
    Overeem, Lucas Hendrik
    Ornello, Raffaele
    Pocora, Maria Magdalena
    Reuter, Uwe
    Sacco, Simona
    Tassorelli, Cristina
    Dueland, Aud Nome
    Raffaelli, Bianca
    Martinelli, Daniele
    CNS DRUGS, 2023, 37 (05) : 453 - 465
  • [39] A retrospective real-life multicenter study on concurrent oral preventives in patients with chronic migraine treated with botulinum toxin
    Overeem, L. H.
    Ornello, R.
    Pocora, M. M.
    Dueland, A. N.
    Sacco, S.
    Tassorelli, C.
    Reuter, U.
    Raffaelli, B.
    Martinelli, D.
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
  • [40] A Retrospective Real-Life Multicenter Study on Concurrent Oral Preventive Treatments in Patients with Chronic Migraine Treated with OnabotulinumtoxinA
    Lucas Hendrik Overeem
    Raffaele Ornello
    Maria Magdalena Pocora
    Uwe Reuter
    Simona Sacco
    Cristina Tassorelli
    Aud Nome Dueland
    Bianca Raffaelli
    Daniele Martinelli
    CNS Drugs, 2023, 37 : 453 - 465
12345